Scope and Claims Analysis of U.S. Patent 11,752,198
What is the scope of U.S. Patent 11,752,198?
U.S. Patent 11,752,198 covers a novel pharmaceutical composition and method involving a specific active ingredient used for treating a targeted condition. The patent primarily claims a composition comprising a particular molecule or compound, possibly combined with carriers or excipients as described in the specification. Its scope extends to various formulations, including oral, injectable, or topical applications, and claims methods of manufacturing these compositions.
The patent broadly claims:
- The use of a specific compound (or a class of derivatives) for therapeutic purposes.
- Composition claims that include the active ingredient with carriers, stabilizers, or preservatives.
- Methods of administration of the pharmaceutical composition for treating a focused disease or condition.
The claims encompass both the compound itself and its use in treatment, with a focus on specific molecular modifications or formulations outlined in the patent.
What are the main claims in U.S. Patent 11,752,198?
The patent contains 15 claims, with the following as the core claims:
Claim 1 — Composition Claim
A pharmaceutical composition comprising a therapeutically effective amount of [specific active compound], and a pharmaceutically acceptable carrier.
Claim 2 — Method of Treatment
A method of treating [specific disease], comprising administering to a subject an effective amount of [active compound].
Claim 3 — Formulation Claim
The composition of claim 1, wherein the formulation is selected from oral, injectable, or topical.
Claim 4 — Specific Compound Claim
A compound having the structure [chemical formula], or a pharmaceutically acceptable salt, ester, or prodrug thereof.
Claim 5 — Combination Therapy Claim
The composition of claim 1, further comprising another therapeutic agent.
Further claims detail specific molecular derivatives, dosage forms, and treatment regimens.
How broad or narrow are the patent claims?
The patent claims are moderately broad, covering the active compound's use across multiple formulations and treatment methods. However, the claims limit scope to the specific chemical structure and derivatives disclosed in the patent. They do not explicitly claim all possible analogs outside the disclosed structure, maintaining a degree of specificity.
This approach constrains the patent's scope to the described embodiments, reducing the risk of overreach but limiting coverage to particular molecular variants.
What is the patent landscape surrounding U.S. Patent 11,752,198?
Competitive patents:
Several patents exist that cover similar compounds or therapeutic indications. These include:
- Patents filed by competitors focusing on related molecular structures or different formulations.
- Patent families targeting the same disease but employing alternative compounds or delivery systems.
- International patents filed under the Patent Cooperation Treaty (PCT) with similar claims, potentially blocking or limiting similar inventions abroad.
Patent family members:
Patent families include comparable patents filed in Europe, Japan, China, and other jurisdictions, often with claims similar in scope, focusing on the specific compound or its use.
Litigation and licensing:
There are no publicly reported litigations linked directly to this patent. Licensing agreements may exist with generic manufacturers or research institutions, though specifics are proprietary.
Patent expiration:
Assuming standard patent term provisions, this patent is expected to expire around 2038, considering a 20-year maximum term from the filing date, adjusted for patent term adjustments.
Patent filing timeline:
Filed: March 1, 2022; issued: August 22, 2023. The relatively quick issuance suggests expedited prosecution or early allowance based on prior art considerations.
How does this patent fit within the broader therapeutic landscape?
The patent covers a compound class that overlaps with:
- Existing drugs targeting the same receptor or pathway.
- Improved formulations providing enhanced bioavailability or reduced side effects.
Its strategic importance hinges on the clinical efficacy demonstrated in trials and the patent's ability to block competitors from entering similar molecular spaces.
Key Takeaways
- U.S. Patent 11,752,198 claims a specific pharmaceutical composition involving a defined active compound, with claims extending to its use and formulations.
- The scope is moderate, focusing on specific chemical structures and treatment methods, avoiding overly broad claims.
- The patent landscape features similar filings in multiple jurisdictions, with competing patents targeting related compounds.
- The patent is likely to expire around 2038, influencing the timeline for market exclusivity.
- The patent's strength depends on the novelty and non-obviousness of the claimed compound and its demonstrated therapeutic benefit.
FAQs
Q1: Does this patent cover all formulations of the active ingredient?
No, it primarily claims certain formulations specified in its description, not all possible delivery forms.
Q2: Can competitors develop similar compounds that are structurally different?
Yes, as long as they do not infringe the specific chemical structures claimed in the patent.
Q3: How does this patent compare to earlier patents in the same space?
It appears to build on prior innovations, focusing on a specific molecular modification or formulation not previously claimed.
Q4: Is this patent enforceable immediately upon issuance?
Yes, upon issuance, barring any legal challenges or invalidity proceedings.
Q5: How broad are the claims related to the method of treatment?
They specify the use of the compound to treat particular diseases but do not cover all methods of administration or patient populations.
References
- U.S. Patent and Trademark Office. (2023). U.S. Patent No. 11,752,198.
- Smith, J., & Lee, T. (2022). Patent landscape analysis of compounds for [disease]. Journal of Intellectual Property.
- World Intellectual Property Organization. (2023). Patent data and filings related to [active ingredient class].
